Published in Am J Pathol on June 26, 2008
p53 and metabolism. Nat Rev Cancer (2009) 5.05
The nucleolus under stress. Mol Cell (2010) 3.63
Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am J Pathol (2009) 1.87
Nucleolar targeting: the hub of the matter. EMBO Rep (2009) 1.82
When ribosomes go bad: diseases of ribosome biogenesis. Mol Biosyst (2010) 1.76
Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS One (2011) 1.53
Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Am J Pathol (2012) 1.45
Are snoRNAs and snoRNA host genes new players in cancer? Nat Rev Cancer (2012) 1.44
Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1. Blood (2015) 1.40
A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell (2014) 1.35
Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. Mol Cell (2012) 1.24
Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLoS One (2010) 1.16
Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene. Am J Pathol (2011) 1.12
Enigmatic MYC Conducts an Unfolding Systems Biology Symphony. Genes Cancer (2010) 1.11
Emerging roles of the nucleolus in regulating the DNA damage response: the noncanonical DNA repair enzyme APE1/Ref-1 as a paradigmatical example. Antioxid Redox Signal (2013) 1.08
Transcriptomic signatures in cartilage ageing. Arthritis Res Ther (2013) 1.07
mTOR signaling regulates the processing of pre-rRNA in human cells. Nucleic Acids Res (2011) 1.05
Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. Am J Pathol (2009) 1.05
Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction. Genome Med (2013) 1.05
Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology (2012) 1.01
Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA. Proc Natl Acad Sci U S A (2013) 1.00
Tissue type-specific expression of the dsRNA-binding protein 76 and genome-wide elucidation of its target mRNAs. PLoS One (2010) 1.00
Measuring the dynamics of E. coli ribosome biogenesis using pulse-labeling and quantitative mass spectrometry. Mol Biosyst (2012) 0.99
Immunogenicity of autoantigens. BMC Genomics (2011) 0.97
The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor. J Biol Chem (2009) 0.97
A proteomic screen for nucleolar SUMO targets shows SUMOylation modulates the function of Nop5/Nop58. Mol Cell (2010) 0.97
Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells. Cancer Metab (2013) 0.96
Poly(ADP-Ribose) polymerase 1 (PARP-1) regulates ribosomal biogenesis in Drosophila nucleoli. PLoS Genet (2012) 0.96
Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle? J Mol Med (Berl) (2012) 0.96
DKC1 overexpression associated with prostate cancer progression. Br J Cancer (2009) 0.95
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Oncogene (2014) 0.95
Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription. Hum Mol Genet (2014) 0.92
Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses. Cell Death Differ (2012) 0.92
A conserved deubiquitinating enzyme controls cell growth by regulating RNA polymerase I stability. Cell Rep (2012) 0.92
Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription. Oncogene (2012) 0.91
Surviving hypoxia by modulation of mRNA translation rate. J Cell Mol Med (2009) 0.91
Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells. Mol Cell Biol (2009) 0.90
MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer. Radiol Oncol (2013) 0.90
Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells. Evid Based Complement Alternat Med (2013) 0.89
TFIIB-related factors in RNA polymerase I transcription. Biochim Biophys Acta (2012) 0.89
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate. Oncogene (2015) 0.88
Role of ribosomal protein mutations in tumor development (Review). Int J Oncol (2016) 0.88
Regulation of rDNA transcription by proto-oncogene PELP1. PLoS One (2011) 0.88
Molecular genetics of ependymoma. Chin J Cancer (2011) 0.87
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation. BMC Cancer (2011) 0.87
Loss of MTG16a (CBFA2T3), a novel rDNA repressor, leads to increased ribogenesis and disruption of breast acinar morphogenesis. J Cell Mol Med (2009) 0.87
Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus. PLoS One (2012) 0.87
Transgenerational inheritance of diet-induced genome rearrangements in Drosophila. PLoS Genet (2015) 0.87
Mitomycin C inhibits ribosomal RNA: a novel cytotoxic mechanism for bioreductive drugs. J Biol Chem (2010) 0.87
A cell cycle role for the epigenetic factor CTCF-L/BORIS. PLoS One (2012) 0.87
A conserved quality-control pathway that mediates degradation of unassembled ribosomal proteins. Elife (2016) 0.86
Ubiquitin and ubiquitin-like proteins in the nucleolus: multitasking tools for a ribosome factory. Genes Cancer (2010) 0.86
An intergenic non-coding rRNA correlated with expression of the rRNA and frequency of an rRNA single nucleotide polymorphism in lung cancer cells. PLoS One (2009) 0.86
The cell's nucleolus: an emerging target for chemotherapeutic intervention. ChemMedChem (2013) 0.86
rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis. Oncotarget (2015) 0.85
The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. Oncogene (2015) 0.85
Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress. Nucleic Acids Res (2013) 0.85
Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors. Nucleic Acids Res (2014) 0.85
P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate. Mol Cell Biol (2013) 0.84
Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9. J Virol (2012) 0.84
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility? Oncotarget (2015) 0.84
New insights into nucleolar structure and function. F1000Prime Rep (2015) 0.83
Structure and function of the N-terminal nucleolin binding domain of nuclear valosin-containing protein-like 2 (NVL2) harboring a nucleolar localization signal. J Biol Chem (2011) 0.82
Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours. Virchows Arch (2011) 0.82
Nucleolar localization and identification of nuclear/nucleolar localization signals of the calmodulin-binding protein nucleomorphin during growth and mitosis in Dictyostelium. Histochem Cell Biol (2011) 0.82
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas. BMC Cancer (2014) 0.82
Fam40b is required for lineage commitment of murine embryonic stem cells. Cell Death Dis (2014) 0.81
Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress. Mol Cancer Ther (2014) 0.81
Cardiomyopathy is associated with ribosomal protein gene haplo-insufficiency in Drosophila melanogaster. Genetics (2011) 0.81
Genetics of ribosomal proteins: "curiouser and curiouser". PLoS Genet (2013) 0.81
Arabidopsis NMD3 is required for nuclear export of 60S ribosomal subunits and affects secondary cell wall thickening. PLoS One (2012) 0.81
Identification of novel markers that demarcate the nucleolus during severe stress and chemotherapeutic treatment. PLoS One (2013) 0.80
In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency. PLoS Genet (2015) 0.80
Finding minimum gene subsets with heuristic breadth-first search algorithm for robust tumor classification. BMC Bioinformatics (2012) 0.80
Evolution of network biomarkers from early to late stage bladder cancer samples. Biomed Res Int (2014) 0.80
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. Onco Targets Ther (2013) 0.80
Serum non-coding RNAs as biomarkers for osteoarthritis progression after ACL injury. Osteoarthritis Cartilage (2012) 0.80
Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress. Int J Mol Sci (2017) 0.79
Metabolic and protein interaction sub-networks controlling the proliferation rate of cancer cells and their impact on patient survival. Sci Rep (2013) 0.79
Ribosome synthesis and MAPK activity modulate ionizing radiation-induced germ cell apoptosis in Caenorhabditis elegans. PLoS Genet (2013) 0.79
The RNA recognition motif of NIFK is required for rRNA maturation during cell cycle progression. RNA Biol (2015) 0.78
PHF6 Degrees of Separation: The Multifaceted Roles of a Chromatin Adaptor Protein. Genes (Basel) (2015) 0.78
eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling. Oncotarget (2015) 0.78
Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma. Cancer Cell (2017) 0.78
Automated image based prominent nucleoli detection. J Pathol Inform (2015) 0.77
Determinants of mammalian nucleolar architecture. Chromosoma (2015) 0.77
Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells. Oncotarget (2015) 0.77
Effect of CAL-101, a PI3Kδ inhibitor, on ribosomal rna synthesis and cell proliferation in acute myeloid leukemia cells. Blood Cancer J (2014) 0.77
Structural dynamics of the yeast Shwachman-Diamond syndrome protein (Sdo1) on the ribosome and its implication in the 60S subunit maturation. Protein Cell (2016) 0.77
The ATPase hCINAP regulates 18S rRNA processing and is essential for embryogenesis and tumour growth. Nat Commun (2016) 0.77
Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart. Cell Death Dis (2011) 0.77
The transcription factor EGR1 localizes to the nucleolus and is linked to suppression of ribosomal precursor synthesis. PLoS One (2014) 0.77
Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas. BMJ Open (2014) 0.76
Recent progress in histochemistry and cell biology. Histochem Cell Biol (2012) 0.76
PPM1D controls nucleolar formation by up-regulating phosphorylation of nucleophosmin. Sci Rep (2016) 0.75
Modified Method of rRNA Structure Analysis Reveals Novel Characteristics of Box C/D RNA Analogues. Acta Naturae (2015) 0.75
Functional analysis of a novel glioma antigen, EFTUD1. Neuro Oncol (2014) 0.75
Spt6 Is Essential for rRNA Synthesis by RNA Polymerase I. Mol Cell Biol (2015) 0.75
Eosinophilic nucleoli. J Oral Maxillofac Pathol (2014) 0.75
Surfing the p53 network. Nature (2000) 35.36
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
p53 in health and disease. Nat Rev Mol Cell Biol (2007) 11.33
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev (2003) 8.00
A telomerase component is defective in the human disease dyskeratosis congenita. Nature (1999) 7.91
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature (1990) 7.74
Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93
Does the ribosome translate cancer? Nat Rev Cancer (2003) 6.89
Size control in animal development. Cell (1999) 6.39
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet (1999) 6.23
The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev (2000) 5.93
Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol (1999) 5.78
Principles of tumor suppression. Cell (2004) 5.52
Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J (1986) 5.31
The Pezcoller lecture: cancer cell cycles revisited. Cancer Res (2000) 5.08
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med (2004) 5.01
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol (2005) 4.89
The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol (2001) 4.83
Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (1989) 4.65
Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet (2002) 4.62
Extraribosomal functions of ribosomal proteins. Trends Biochem Sci (1996) 4.25
Role of nucleophosmin in embryonic development and tumorigenesis. Nature (2005) 4.09
Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol (2004) 3.99
Dyskeratosis congenita in all its forms. Br J Haematol (2000) 3.89
Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev (2003) 3.85
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol (2005) 3.79
The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev (1999) 3.50
Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature (1995) 3.41
Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science (2006) 3.37
The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol (2006) 3.31
Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol (2004) 3.26
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science (2003) 3.18
Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet (2006) 3.17
Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science (2000) 3.07
Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature (1996) 3.04
The RNA of RNase MRP is required for normal processing of ribosomal RNA. Proc Natl Acad Sci U S A (1994) 2.68
A mammalian mitochondrial RNA processing activity contains nucleus-encoded RNA. Science (1987) 2.63
Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol (1995) 2.62
The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet (2007) 2.58
Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group. Nat Genet (1996) 2.40
An encore for ribosome biogenesis in the control of cell proliferation. Nat Cell Biol (2000) 2.28
The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci U S A (2004) 2.27
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev (2006) 2.20
Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol Cell Biol (2000) 2.10
Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system. Proc Natl Acad Sci U S A (1992) 2.08
Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J (1999) 2.04
Cellular stress and nucleolar function. Cell Cycle (2005) 1.88
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J (1990) 1.84
The nucleolus--a gateway to viral infection? Arch Virol (2002) 1.84
Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein. Mol Cell Biol (1997) 1.82
A role for c-Myc in the regulation of ribosomal RNA processing. Nucleic Acids Res (2003) 1.80
Specific Role for Yeast Homologs of the Diamond Blackfan Anemia-associated Rps19 Protein in Ribosome Synthesis. J Biol Chem (2005) 1.79
Nucleolar function and size in cancer cells. Am J Pathol (1998) 1.66
The AgNORs. Micron (2000) 1.61
Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol (2000) 1.59
HBV induced carcinogenesis. J Clin Virol (2005) 1.56
Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology (1997) 1.52
Structure and function of the nucleolus in the spotlight. Curr Opin Cell Biol (2006) 1.51
AgNOR staining and quantification. Micron (2000) 1.49
Conventional and nonconventional roles of the nucleolus. Int Rev Cytol (2002) 1.43
Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth. Mol Cell Biol (1993) 1.41
Preneoplastic lesions in human hepatocarcinogenesis. Liver Int (2005) 1.33
Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene (2002) 1.31
Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. Hepatology (2005) 1.30
Ribosomal proteins in cell proliferation and apoptosis. Int Rev Immunol (1999) 1.28
The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation. Hum Mol Genet (2005) 1.25
Immunopurified small nucleolar ribonucleoprotein particles pseudouridylate rRNA independently of their association with phosphorylated Nopp140. Mol Cell Biol (2002) 1.23
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol (2006) 1.20
Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet (2005) 1.19
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol (1998) 1.19
Overlapping functions of the pRb family in the regulation of rRNA synthesis. Mol Cell Biol (2001) 1.18
Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1. Oncogene (2000) 1.17
Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation. Oncogene (2006) 1.14
Nucleolar adaptation in human cancer. Cancer Invest (2005) 1.13
Regulation of the G1 phase of the mammalian cell cycle. Cell Res (2000) 1.13
The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron (2000) 1.07
Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies. Clin Gastroenterol Hepatol (2005) 1.06
Nucleolar size and activity are related to pRb and p53 status in human breast cancer. J Histochem Cytochem (2004) 1.04
Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol (1991) 1.03
Telomeres, the nucleolus and aging. Curr Opin Cell Biol (1998) 0.99
Phylogeny, sequence conservation, and functional complementation of the SBDS protein family. Genomics (2006) 0.96
Initiation of mRNA translation in oncogenesis: the role of eIF4E. Cell Cycle (2004) 0.93
Activation of RNA polymerase I transcription by hepatitis C virus core protein. J Biomed Sci (2004) 0.92
Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease? J Clin Pathol (1993) 0.90
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J Clin Pathol (2004) 0.89
HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice. Hepatology (2006) 0.89
Deregulation of cell growth and malignant transformation. Croat Med J (2005) 0.88
Structural organization of the nucleolus in mammalian cells. Methods Achiev Exp Pathol (1986) 0.87
Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection. Hepatology (2003) 0.85
The flexible evolutionary anchorage-dependent Pardee's restriction point of mammalian cells: how its deregulation may lead to cancer. Biochim Biophys Acta (2005) 0.85
Relationship between interphase AgNOR distribution and nucleolar size in cancer cells. Histochem J (1992) 0.84
Do truncated cyclins contribute to aberrant cyclin expression in cancer? Cell Cycle (2006) 0.83
Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis. J Clin Pathol (2003) 0.78
What the nucleolus says to a tumour pathologist. Histopathology (2009) 1.38
Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res (2012) 1.24
Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim Biophys Acta (2011) 1.16
Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res (2010) 1.07
Nucleolar size and activity are related to pRb and p53 status in human breast cancer. J Histochem Cytochem (2004) 1.04
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. Clin Cancer Res (2008) 1.02
Partial persistence of exercise-induced myocardial angiogenesis following 4-week detraining in the rat. Histochem Cell Biol (2008) 1.01
Genetic pathways in the evolution of breast ductal carcinoma in situ. J Pathol (2002) 1.00
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. J Cell Sci (2011) 0.97
Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines. J Invest Dermatol (2002) 0.93
GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation. Hum Pathol (2005) 0.91
Cell proliferation in breast cancer is a major determinant of clinical outcome in node-positive but not in node-negative patients. Appl Immunohistochem Mol Morphol (2006) 0.90
Relationship between dyskerin expression and telomerase activity in human breast cancer. Cell Oncol (2008) 0.89
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. World J Gastroenterol (2004) 0.88
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. Nucleic Acids Res (2013) 0.87
Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection. Hepatology (2003) 0.85
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. J Pathol (2009) 0.85
Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells. J Cell Physiol (2005) 0.84
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas. BMC Cancer (2014) 0.82
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. Onco Targets Ther (2013) 0.80
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. World J Gastroenterol (2009) 0.79
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury. ScientificWorldJournal (2012) 0.79
SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. Int J Mol Sci (2013) 0.79
Liver-targeted doxorubicin: effects on rat regenerating hepatocytes. Liver Int (2004) 0.78
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness. Histopathology (2014) 0.77
Location of rRNA transcription to the nucleolar components: disappearance of the fibrillar centers in nucleoli of regenerating rat hepatocytes. Cell Struct Funct (2011) 0.76
Evaluation of thymidylate synthase protein expression by Western blotting and immunohistochemistry on human colon carcinoma xenografts in nude mice. J Histochem Cytochem (2002) 0.76
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease. World J Gastroenterol (2011) 0.75
DKC1 gene mutations in human sporadic cancer. Histol Histopathol (2013) 0.75